|
Mutation Information
|
Mutation Site
|
D67N |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
NRTIs |
|
Country
|
Thailand |
Literature Information
|
PubMed PMID
|
20158398
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2010 |
|
Journal
|
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
|
Title
|
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine. |
|
Author
|
Lallemant M,Ngo-Giang-Huong N,Jourdain G,Traisaithit P,Cressey TR,Collins IJ,Jarupanich T,Sukhumanant T,Achalapong J,Sabsanong P,Chotivanich N,Winiyakul N,Ariyadej S,Kanjanasing A,Ratanakosol J,Hemvuttiphan J,Kengsakul K,Wannapira W,Sittipiyasakul V,Pornkitprasarn W,Liampongsabuddhi P,McIntosh K,Van Dyke RB,Frenkel LM,Koetsawang S,Le Coeur S,Kanchana S,PHPT-4 Study Team. |
|
Evidence
|
After a median antepartum zidovudine duration of 10.4 weeks in both groups and an additional 4 weeks postpartum zidovudine-plus-didanosine in PHPT-4, new NRTI resistance mutations were detected by consensus sequencing in five PHPT-4 subjects (2.3%; four K70R and one D67N+K70R) and two PHPT-2 controls (0.9%; one D67N, one K70R) (Table 4).
|
|
|
HIV Mutation Detail Information